"With Inari as the mechanical thrombectomy leader in pulmonary embolism (PE) and deep vein thrombosis (DVT), Inari's products could now bolster the neurovascular subsegment that represents a $1.3 ...

Several spine and orthopedic companies have made progress with acquisitions in the first quarter of 2025. 1. Stryker has ...

Pulmonary embolism occurs when an embolus breaks away from a thrombus and blocks the pulmonary artery, generating symptoms that include shortness of breath, chest pain, fainting and haemoptysis.

Shares of Inari Medical, Inc. (NASDAQ:NARI – Get Free Report) have been given an average rating of “Hold” by the fourteen brokerages that are currently covering the stock, MarketBeat reports. Twelve ...

Inari Medical, Inc. (NASDAQ ... to treat venous thromboembolism (VTE), deep vein thrombosis (DVT), and pulmonary embolism (PE). The company also has an InThrill system that removes emboli and ...

California-based Inari, which was founded in 2013, is a maker of devices and systems that treat patients suffering from a variety of blood clot conditions including pulmonary embolism, deep vein ...

A study analysing data from the US Renal Data System has revealed a significant risk of pulmonary embolism in patients with ...